AstraZeneca submits new data showing its vaccine is 76 percent effective
Drugmaker AstraZeneca has sought to quell a week-long dust-up over its coronavirus (COVID-19) trial results, issuing new data that suggests the vaccine is 76 percent effective against the virus. Previous results, released on Monday, declared that the vaccine had an efficacy rate of 79 percent. The f...